We conducted this meta-analysis of double-blind randomized placebo-controlled trials to
estimate the efficacy of omega-3 polyunsaturated fatty acids (PUFAs), especially …

Background Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in
depressed patients have been suggested to improve depressive symptomatology, previous …

Omega-3 polyunsaturated fatty acid (PUFA) supplementation has been proposed as
(adjuvant) treatment for major depressive disorder (MDD). In the present meta-analysis, we …

Marine-based fish and fish oil are the most popular and well-known sources of n-3
polyunsaturated fatty acids (PUFAs), namely, eicosapentaenoic acid (EPA) and …

Major depressive disorder (MDD) is a complex illness and it is likely that alterations in
several interacting systems underlie its pathogenesis. Numerous hypotheses have been …

Background Major depressive disorder (MDD) is highly debilitating, difficult to treat, has a
high rate of recurrence, and negatively impacts the individual and society as a whole. One …

A new application for omega-3 fatty acids has recently emerged, concerning the treatment of
several mental disorders. This indication is supported by data of neurobiological research …

Purpose Immune imbalances in major depressive disorder (MDD) have been targeted by
anti-inflammatory treatment approaches in clinical trials to increase responsiveness to …

Inflammation is involved in the pathophysiology of many chronic diseases, such as
rheumatoid arthritis and neurodegenerative diseases. Several studies have evidenced …

Los ácidos grasos poliinsaturados de cadena larga omega-3 (AGPICL ω-3) como el ácido
eicosapentaenoico (EPA) y docosahexaenoico (DHA) se encuentran en cantidades …